Physician profile
Grace E Onuma
NPI 1164800108
$3,701.97
in general payments reported to CMS, 2019-2025
26 companies · $532 in 2025
The $532 reported for 2025 was more than what 75% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $335 · 2022: $332 · 2023: $1,346 · 2024: $1,157 · 2025: $532.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,035.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,034.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,056.89 | 2022-2025 | |
| Amgen INC. | $641.57 | 2021-2025 | Repatha, Otezla, Evenity |
| Novo Nordisk INC | $398.47 | 2021-2024 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $331.32 | 2021-2024 | Jardiance, Mounjaro, Emgality |
| Astrazeneca Pharmaceuticals Lp | $324.96 | 2021-2024 | Airsupra, Farxiga, Breztri |
| Esperion Therapeutics, INC. | $124.99 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $117.97 | 2021-2024 | Jardiance, Synjardy |
| Glaxosmithkline, LLC. | $102.61 | 2023-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Pfizer INC. | $94.34 | 2023-2025 | |
| Phathom Pharmaceuticals, INC. | $62.67 | 2025 | Voquezna |
| Corcept Therapeutics | $52.58 | 2025 | Korlym |
| Sunovion Pharmaceuticals INC. | $48.59 | 2021 | |
| Inspire Medical Systems, INC. | $48.25 | 2025 | Inspire |
| Angiodynamics, INC. | $37.94 | 2024 | Auryon Laser System 100-120 Vac |
| Abbott Laboratories | $35.56 | 2021-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $32.76 | 2023-2024 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $25.13 | 2022 | |
| Exact Sciences Corporation | $24.71 | 2023 | Cologuard Collection Kit |
| Tactile Systems Technology INC | $23.77 | 2024 | Flexitouch Plus, Entre Plus |
| Inari Medical, INC. | $21.24 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Astellas Pharma US INC | $17.95 | 2023 | Veozah |
| Tris Pharma INC | $17.95 | 2024 | Dyanavel Xr |
| Eisai INC. | $15.73 | 2021 | |
| Medtronic, INC. | $15.32 | 2022 | |
| Janssen Pharmaceuticals, INC | $15.31 | 2022 | |
| Merck Sharp & Dohme LLC | $13.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grace Onuma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.